The global asthma and COPD drugs market is experiencing substantial growth as respiratory diseases continue to represent a major healthcare challenge worldwide. Asthma and chronic obstructive pulmonary disease (COPD) affect millions of individuals, leading to significant healthcare costs, reduced quality of life, and increased demand for effective treatment solutions. Advancements in...